These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10778971)

  • 1. Allelic loss and microsatellite alterations of chromosome 3p14.2 are more frequent in recurrent cervical dysplasias.
    Lin WM; Michalopulos EA; Dhurander N; Cheng PC; Robinson W; Ashfaq R; Coleman RL; Muller CY
    Clin Cancer Res; 2000 Apr; 6(4):1410-4. PubMed ID: 10778971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution.
    Chu TY; Shen CY; Lee HS; Liu HS
    Genes Chromosomes Cancer; 1999 Feb; 24(2):127-34. PubMed ID: 9885979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia.
    Luft F; Gebert J; Schneider A; Melsheimer P; von Knebel Doeberitz M
    Int J Gynecol Pathol; 1999 Oct; 18(4):374-80. PubMed ID: 10542947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV infection and microsatellite instability in squamous lesions of the uterine cervix.
    French D; Cermele C; Vecchione A; Cenci M; Vecchione A
    Anticancer Res; 2000; 20(5B):3417-21. PubMed ID: 11131642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study.
    Migdalska-Sęk M; Karowicz-Bilińska A; Pastuszak-Lewandoska D; Czarnecka KH; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
    Med Oncol; 2016 May; 33(5):51. PubMed ID: 27090798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer.
    Nishimura M; Furumoto H; Kato T; Kamada M; Aono T
    Gynecol Oncol; 2000 Nov; 79(2):201-6. PubMed ID: 11063644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions.
    Terry G; Ho L; Londesborough P; Cross P; Lopes A; Monaghan J; Cuzick J
    Br J Cancer; 2004 Dec; 91(12):2056-62. PubMed ID: 15570308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p.
    Rader JS; Gerhard DS; O'Sullivan MJ; Li Y; Li L; Liapis H; Huettner PC
    Genes Chromosomes Cancer; 1998 May; 22(1):57-65. PubMed ID: 9591635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma.
    Wistuba II; Montellano FD; Milchgrub S; Virmani AK; Behrens C; Chen H; Ahmadian M; Nowak JA; Muller C; Minna JD; Gazdar AF
    Cancer Res; 1997 Aug; 57(15):3154-8. PubMed ID: 9242443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on the short arm of chromosome 3 in cervical intra-epithelial neoplasia without concomitant cervical carcinoma.
    Fouret PJ; Dabit D; Mergui JL; Uzan S
    Pathobiology; 1998; 66(6):306-10. PubMed ID: 9769478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features.
    Butler D; Collins C; Mabruk M; Barry Walsh C; Leader MB; Kay EW
    J Pathol; 2000 Dec; 192(4):502-10. PubMed ID: 11113868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA.
    Chu TY; Shen CY; Chiou YS; Lu JJ; Perng CL; Yu MS; Liu HS
    Int J Cancer; 1998 Jan; 75(2):199-204. PubMed ID: 9462708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22.
    van Duin M; Steenbergen RD; de Wilde J; Helmerhorst TJ; Verheijen RH; Risse EK; Meijer CJ; Snijders PJ
    Int J Cancer; 2003 Jul; 105(5):577-82. PubMed ID: 12740903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions.
    Wang L; Shen H; Feng B; Zhu D; Yu L; Tian X; Ren C; Gao C; Li X; Ma D; Hu Z; Wang H
    PLoS One; 2017; 12(4):e0175520. PubMed ID: 28414756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
    Nagai Y; Maehama T; Asato T; Kanazawa K
    Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of molecular changes in cervical intraepithelial neoplasia in HIV-positive and HIV-indeterminate subjects.
    Wistuba II; Syed S; Behrens C; Duong M; Milchgrub S; Muller CY; Jagirdar J; Gazdar AF
    Gynecol Oncol; 1999 Sep; 74(3):519-26. PubMed ID: 10479524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.